These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 23263904)
1. Impact of lymph node ratio on survival in papillary thyroid cancer. Schneider DF; Chen H; Sippel RS Ann Surg Oncol; 2013 Jun; 20(6):1906-11. PubMed ID: 23263904 [TBL] [Abstract][Full Text] [Related]
2. Lymph node ratio as a tool to stratify patients with N1b papillary thyroid cancer. Luo Z; Hei H; Qin J; Zheng C; Gong W; Zhou B Langenbecks Arch Surg; 2023 Aug; 408(1):315. PubMed ID: 37584830 [TBL] [Abstract][Full Text] [Related]
4. Optimal Cut-Off Values of Lymph Node Ratio Predicting Recurrence in Papillary Thyroid Cancer. Lee SG; Ho J; Choi JB; Kim TH; Kim MJ; Ban EJ; Lee CR; Kang SW; Jeong JJ; Nam KH; Jung SG; Jo YS; Lee J; Chung WY Medicine (Baltimore); 2016 Feb; 95(5):e2692. PubMed ID: 26844509 [TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer. Wu MH; Shen WT; Gosnell J; Duh QY Head Neck; 2015 Sep; 37(9):1336-43. PubMed ID: 24821456 [TBL] [Abstract][Full Text] [Related]
6. Prognostic implications of lymph node yield and lymph node ratio in papillary thyroid carcinoma. Vas Nunes JH; Clark JR; Gao K; Chua E; Campbell P; Niles N; Gargya A; Elliott MS Thyroid; 2013 Jul; 23(7):811-6. PubMed ID: 23373961 [TBL] [Abstract][Full Text] [Related]
7. Restratification of survival prognosis of N1b papillary thyroid cancer by lateral lymph node ratio and largest lymph node size. Kim HI; Kim TH; Choe JH; Kim JH; Kim JS; Oh YL; Hahn SY; Shin JH; Jang HW; Kim YN; Kim H; Ahn HS; Kim K; Kim SW; Chung JH Cancer Med; 2017 Oct; 6(10):2244-2251. PubMed ID: 28857489 [TBL] [Abstract][Full Text] [Related]
8. Occult lymph node metastasis and risk of regional recurrence in papillary thyroid cancer after bilateral prophylactic central neck dissection: A multi-institutional study. Lee YC; Na SY; Park GC; Han JH; Kim SW; Eun YG Surgery; 2017 Feb; 161(2):465-471. PubMed ID: 27574773 [TBL] [Abstract][Full Text] [Related]
10. Lymph node ratio in lateral neck is an independent risk factor for recurrence-free survival in papillary thyroid cancer patients with positive lymph nodes. Luo Z; Hei H; Qin J; Zheng C; Gong W Endocrine; 2022 Dec; 78(3):484-490. PubMed ID: 36018538 [TBL] [Abstract][Full Text] [Related]
11. Lymph node ratio (LNR) as a complementary staging system to TNM staging in salivary gland cancer. Lei BW; Hu JQ; Yu PC; Wang YL; Wei WJ; Zhu J; Shi X; Qu N; Lu ZW; Ji QH Eur Arch Otorhinolaryngol; 2019 Dec; 276(12):3425-3434. PubMed ID: 31511971 [TBL] [Abstract][Full Text] [Related]
12. Nodal status, number of lymph nodes examined, and lymph node ratio: what defines prognosis after resection of colon adenocarcinoma? Gleisner AL; Mogal H; Dodson R; Efron J; Gearhart S; Wick E; Lidor A; Herman JM; Pawlik TM J Am Coll Surg; 2013 Dec; 217(6):1090-100. PubMed ID: 24045143 [TBL] [Abstract][Full Text] [Related]
13. Recurrence factors and prevention of complications of pediatric differentiated thyroid cancer. Wang C; Chen X; Wei X; Chen F; Wang Y; Shen Z Asian J Surg; 2017 Jan; 40(1):55-60. PubMed ID: 27697309 [TBL] [Abstract][Full Text] [Related]
14. Cervical lymph node metastasis and papillary thyroid carcinoma: does the compartment involved affect survival? Experience from the SEER database. Smith VA; Sessions RB; Lentsch EJ J Surg Oncol; 2012 Sep; 106(4):357-62. PubMed ID: 22392921 [TBL] [Abstract][Full Text] [Related]
15. Number of positive nodes is superior to the lymph node ratio and American Joint Committee on Cancer N staging for the prognosis of surgically treated head and neck squamous cell carcinomas. Roberts TJ; Colevas AD; Hara W; Holsinger FC; Oakley-Girvan I; Divi V Cancer; 2016 May; 122(9):1388-97. PubMed ID: 26969807 [TBL] [Abstract][Full Text] [Related]
16. The prognostic value of lymph node ratio in Medullary thyroid carcinoma: A multi-center study. Rozenblat T; Hirsch D; Robenshtok E; Grozinsky-Glasberg S; Gross DJ; Mazeh H; Benbassat C; Twito O; Levy S; Mizrachi A; Shpitzer T; Bachar G Eur J Surg Oncol; 2020 Nov; 46(11):2023-2028. PubMed ID: 32389525 [TBL] [Abstract][Full Text] [Related]
17. Impact of lymph node ratio on the survival of patients with hypopharyngeal squamous cell carcinoma: a population-based analysis. Wang YL; Feng SH; Zhu J; Zhu GP; Li DS; Wang Y; Zhu YX; Sun GH; Ji QH PLoS One; 2013; 8(2):e56613. PubMed ID: 23431384 [TBL] [Abstract][Full Text] [Related]
18. The Prognostic Value of Tumor Multifocality in Clinical Outcomes of Papillary Thyroid Cancer. Wang F; Yu X; Shen X; Zhu G; Huang Y; Liu R; Viola D; Elisei R; Puxeddu E; Fugazzola L; Colombo C; Jarzab B; Czarniecka A; Lam AK; Mian C; Vianello F; Yip L; Riesco-Eizaguirre G; Santisteban P; O'Neill CJ; Sywak MS; Clifton-Bligh R; Bendlova B; Sýkorová V; Wang Y; Liu S; Zhao J; Zhao S; Xing M J Clin Endocrinol Metab; 2017 Sep; 102(9):3241-3250. PubMed ID: 28582521 [TBL] [Abstract][Full Text] [Related]
19. Lymph node ratio of the central compartment is a significant predictor for locoregional recurrence after prophylactic central neck dissection in patients with thyroid papillary carcinoma. Ryu IS; Song CI; Choi SH; Roh JL; Nam SY; Kim SY Ann Surg Oncol; 2014 Jan; 21(1):277-83. PubMed ID: 24006096 [TBL] [Abstract][Full Text] [Related]
20. Impact of extensive neck dissection on survival from papillary thyroid cancer. Kandil E; Friedlander P; Noureldine S; Islam T; Tufano RP ORL J Otorhinolaryngol Relat Spec; 2011; 73(6):330-5. PubMed ID: 21997375 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]